Search Results - "Bowlus CL"

Author Response to "Comment on Prediagnosis Alkaline Phosphatase and Antimitochondrial Antibody Positivity Vary by Race/Ethnicity Among Patients With Primary Biliary Cholangitis".

Authors: Caines A Lu M Wu T et al.

Source: Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2026 Jun; Vol. 41 (6), pp. 1982-1983. Date of Electronic Publication: 2026 Apr 20.

Publication Type: Letter

Journal Info: Publisher: Blackwell Scientific Publications Country of Publication: Australia NLM ID: 8607909 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1440-1746 (Electronic) Linking ISSN: 08159319 NLM ISO Abbreviation: J Gastroenterol Hepatol Subsets: MEDLINE; In Process

Editorial: The evolving paradigms and treatments for primary biliary cholangitis-Authors' reply.

Authors: Mayo MJ Vierling JM Bowlus CL

Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 Jan; Vol. 59 (2), pp. 282.

Publication Type: Editorial; Comment

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE

Editorial: Unravelling real-world impact of second-line therapies in primary biliary cholangitis-Time to change our targets? Authors' reply.

Authors: Fernández-Rodríguez CM Gutierrez ML Olveira A

Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 Jul; Vol. 60 (1), pp. 91-92. Date of Electronic Publication: 2024 May 21.

Publication Type: Editorial; Comment

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE

ASO Author Reflections: Advancing Robotic Liver Surgery for Intrahepatic Cholangiocarcinoma.

Authors: Artaud V Jeddou H

Source: Annals of surgical oncology [Ann Surg Oncol] 2026 Feb; Vol. 33 (2), pp. 1566. Date of Electronic Publication: 2025 Oct 27.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE; In Process

Clover Honey Limits Survival of Enterotoxigenic Escherichia coli in an In Vitro Gastric Model and Reduces In Vitro Fermentation pH of Small Intestine Microbes.

Authors: Traxler S Storms D Faso A et al.

Source: The Journal of nutrition [J Nutr] 2026 Jun; Vol. 156 (6), pp. 101530. Date of Electronic Publication: 2026 Apr 08.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 0404243 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1541-6100 (Electronic) Linking ISSN: 00223166 NLM ISO Abbreviation: J Nutr Subsets: MEDLINE

Association between non-invasive biomarkers and quality of life in Primary Sclerosing Cholangitis.

Authors: Dai, Jingyu Selvaraj, Emmanuel Culver, Emma L. et al.

Source: PLoS ONE. 11/12/2025, Vol. 20 Issue 11, p1-13. 13p.

A multifaceted analysis of OTUD5 integrated MAVS in innate immunity of Primary Biliary Cholangitis.

Authors: Chen, Ran Sun, Yan Tai, Wenlin

Source: PLoS ONE. 2/6/2026, Vol. 21 Issue 2, p1-34. 34p.

Fibrosis stage is an independent predictor of liver‐related complications in primary biliary cholangitis.

Authors: Fujinaga, Yukihisa Namisaki, Tadashi Tsuji, Yuki et al.

Source: Hepatology Research. Jul2025, Vol. 55 Issue 7, p968-976. 9p.

Validation of PBC‐10 in Japanese patients with primary biliary cholangitis.

Authors: Takeuchi, Akihito Abe, Masanori Furukawa, Sachiko et al.

Source: Hepatology Research. Jul2025, Vol. 55 Issue 7, p986-993. 8p.

107例原发性硬化性胆管炎患者的临床特征与预后分析.

Alternate Title: Clinical features and prognosis of patients with primary sclerosing cholangitis： An analysis of 107 cases.

Authors: 孟, 彤彤 段, 维佳 李, 昕宇 et al.

Source: Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi. Jul2025, Vol. 41 Issue 7, p1337-1343. 7p.

Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trial.

Authors: Levy C Abouda GF Bilir BM et al.

Source: Journal of hepatology [J Hepatol] 2026 Jan; Vol. 84 (1), pp. 74-85. Date of Electronic Publication: 2025 May 10.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0641 (Electronic) Linking ISSN: 01688278 NLM ISO Abbreviation: J Hepatol Subsets: MEDLINE

Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trial.

Authors: Trauner M Levy C Tanaka A et al.

Source: The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2026 Jan; Vol. 11 (1), pp. 46-58. Date of Electronic Publication: 2025 Oct 28.

Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study

Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101690683 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-1253 (Electronic) NLM ISO Abbreviation: Lancet Gastroenterol Hepatol Subsets: MEDLINE

Endoscopic Technology for Diagnosis of Biliary Stricture with a Focus on Peroral Cholangioscopy: Challenges in Peroral Cholangioscopy-Based Management.

Authors: Tomishima, Ko Isayama, Hiroyuki Fujisawa, Toshio et al.

Source: Korean Journal of Pancreas & Biliary Tract / Daehan Chwedamdo Haghoeji. Apr2026, Vol. 31 Issue 2, p42-53. 12p.

Stress study of elafibranor and characterization of its degradation impurities using HPLC and LC-MS/MS techniques.

Authors: Bhojegowda, Madhusudana Reddy Muthukurpalya Reddy, Thoorpugadda Raja Palakeeti, Babji et al.

Source: Journal of Applied Pharmaceutical Science. Mar2026, Vol. 16 Issue 3, p301-311. 11p.

Wnt5a基因敲低的M1型骨髓源性巨噬细胞对肝硬化大鼠模型的影响及其作用机制

Alternate Title: Effect and mechanism of Wnt5a knockdown on the efficacy of M1 bone marrow-derived macrophage in treatment of liver cirrhosis.

Authors: 邢, 飞飞 王, 丹阳 郑, 欣瑞 et al.

Source: Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi. Mar2026, Vol. 42 Issue 3, p618-628. 11p.

Editorial: bezafibrate in the treatment of patients with primary biliary cholangitis-are we there yet? Authors' reply.

Authors: Sorda JA González Ballerga E Barreyro FJ et al.

Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 Jan; Vol. 55 (2), pp. 249-250.

Publication Type: Editorial; Comment

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE

Do hepatic and biliary functional data from gadoxetate-enhanced MRI add value in predicting outcomes in primary sclerosing cholangitis (PSC)?

Authors: Sandrasegaran K Shah AS Thompson CP et al.

Source: European radiology [Eur Radiol] 2026 Jun 27. Date of Electronic Publication: 2026 Jun 27.

Publication Type: Journal Article

Journal Info: Publisher: Springer International Country of Publication: Germany NLM ID: 9114774 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1084 (Electronic) Linking ISSN: 09387994 NLM ISO Abbreviation: Eur Radiol Subsets: MEDLINE

Linerixibat: First Approval.

Authors: Hoy SM; Springer Nature, Private Bag 65901, Mairangi Bay, Auckland 0754, New Zealand. dru@adis.com.

Source: Drugs [Drugs] 2026 Jun 16. Date of Electronic Publication: 2026 Jun 16.

Publication Type: Journal Article

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 7600076 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1950 (Electronic) Linking ISSN: 00126667 NLM ISO Abbreviation: Drugs Subsets: MEDLINE

Pemafibrate improves liver biochemistry and GLOBE scores in patients with primary biliary cholangitis: Nationwide, multicenter study by the Japanese Red Cross Liver Study Group.

Authors: Tsuji, Keiji Tamaki, Nobuharu Kurosaki, Masayuki et al.

Source: Hepatology Research. May2025, Vol. 55 Issue 5, p675-684. 10p.

Can a comprehensive gadoxetic acid-enhanced MRI with MRCP be used for early diagnosis, monitoring, and outcome prediction of PSC?

Authors: Poetter-Lang, Sarah Bastati, Nina Attenberger, Ulrike et al.

Source: European Radiology. Dec2024, Vol. 34 Issue 12, p7647-7649. 3p.

Subjects: Liver disease diagnosis, Early diagnosis, Disease risk factors, Medical screening, Endoscopic retrograde cholangiopancreatography